Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

"Privacy and Data Protection: Pharmaceutical and Biotech Industry Privacy Considerations"

Summary

Speakers

Jacqueline Klosek

Related Content

A Look Ahead in Life Sciences: What We Are Tracking in Q2 2024 and Beyond

Washington’s My Health My Data Act Comes Into Force – What You Need to Know, and Do

In Updated Guidance on Use of Tracking Technologies by HIPAA Regulated Entities, HHS-OCR Takes Expansive View of When Information Related to Unauthenticated Individuals Is PHI

European Health Data Space: European Council and European Parliament Strike A Deal

Series 1 - The World’s First AI Regulation Is Here

DoD Significantly Expands Voluntary Cybersecurity Program for Defense Contractors

2023 Year in Review: Data Privacy and Cybersecurity

Shaping the Future: the European Health Data Space

Global Data Review Names Goodwin an Elite Firm in GDR 100 2024

FASHIONPHILE Acquires Two Authenticators Inc. Business

Astera Labs Completes Upsized $774 Million Initial Public Offering

Decoding DOJ's New 'Justice AI' Initiative (Law.com)

NAPCO Securities Technologies Completes $81.5 Million Secondary Offering

Eidos Therapeutics Signs Exclusive License Agreement with Bayer

Goodwin Represents the Initial Purchasers and Dealers on Lyft, Inc.’s $460 million 0.625% Convertible Senior Notes Offering and Capped Call

2024 Children’s Privacy Outlook: Preparing for Regulatory Changes

Data, Privacy & Cybersecurity